ALBERT DAVID
Back to Balance Sheet
|
ALBERT DAVID Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹217 Cr | ₹205 Cr | ₹189 Cr | ₹181 Cr | ₹135 Cr |
What is the latest Total Current Liabilities ratio of ALBERT DAVID ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹217 Cr |
| Mar2024 | ₹205 Cr |
| Mar2023 | ₹189 Cr |
| Mar2022 | ₹181 Cr |
| Mar2021 | ₹135 Cr |
How is Total Current Liabilities of ALBERT DAVID Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹217 Cr | 5.80 | |
| Mar2024 | ₹205 Cr | 8.82 | |
| Mar2023 | ₹189 Cr | 4.19 | |
| Mar2022 | ₹181 Cr | 33.92 | |
| Mar2021 | ₹135 Cr | - | |
Compare Total Current Liabilities of peers of ALBERT DAVID
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALBERT DAVID | ₹390.5 Cr | -0.4% | -9.7% | -41.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,615.0 Cr | 4% | -4.9% | -2.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,943.0 Cr | 1.1% | -9.3% | 9.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,336.0 Cr | -1.3% | -3.7% | 24% | Stock Analytics | |
| CIPLA | ₹107,499.0 Cr | 1.5% | -9.3% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,590.0 Cr | 5% | -0.1% | 3.3% | Stock Analytics | |
ALBERT DAVID Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALBERT DAVID | -0.4% |
-9.7% |
-41.8% |
| SENSEX | 3.5% |
-1.7% |
7.8% |
You may also like the below Video Courses